(Q48196292)

9 February 2018

title

Early ketamine to treat refractory status epilepticus (English)

1 reference

9 February 2018

1 reference

Andreas H Kramer

1

1 reference

9 February 2018

publication date

1 April 2012

1 reference

9 February 2018

published in

Neurocritical Care

1 reference

9 February 2018

volume

16

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

299-305

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s12028-011-9668-7

exact match

0 references

cites work

Management of refractory status epilepticus in adults: still more questions than answers

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Ketamine controls prolonged status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Diagnosis and treatment of status epilepticus on a neurological intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Refractory status epilepticus: response to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Ketamine successfully terminates malignant status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Terminating prolonged refractory status epilepticus using ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Seizure identification in the ICU using quantitative EEG displays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Ketamine Prevents Learning Impairment When Administered Immediately after Status Epilepticus Onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Propofol treatment of refractory status epilepticus: a study of 31 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Oral ketamine in paediatric non-convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Severe refractory status epilepticus owing to presumed encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Glutamate release in severe brain ischaemia is mainly by reversed uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

NMDA receptors: recent insights and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9668-7

Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22237581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Status epilepticus increases the intracellular accumulation of GABAA receptors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22237581

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12028-011-9668-7

1 reference

9 February 2018

1 reference

9 February 2018